Skip to main content

Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold?

04 شباط 2025
Divi's Labs surged 6% after reporting a 64% YoY profit jump in Q3FY25. Revenue rose 25% YoY to Rs 2,319 crore. Goldman Sachs stays Neutral (target: Rs 5,925), while Nuvama maintains Buy (target: Rs 6,830) citing strong growth potential.

For more details: Click here